Companies working with TREAT-NMD
In one form or another, TREAT‐NMD is assisting many companies currently planning or running neuromuscular trials. It is also involved in investigator-led research, and many TREAT-NMD partners are also experienced trial sites taking part in neuromuscular trials.
The list below gives brief details on each company, contact details and links to their respective websites.
OrganisationsBioMarin Pharmaceutical Inc
Founded in 1997 BioMarin has developed and commercialized four products in this time. With over 700 employees and a head office in California, clinica …GMP-Orphan SAS
gmp-orphan (GMPO) is a drug development specialty pharma focused on rare diseases and unmet medical needs. To drop development cost and time to market …Italfarmaco
Italfarmaco, one of the leading Italian pharmaceutical groups, operates in both the pharmaceutical and the fine chemical industries. President of Ital …NicOx S.A.
NicOx is building an international late-stage development and commercial Ophthalmology Company based around therapeutics, diagnostics and devices.Paratek Pharmaceuticals, Inc
Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commerc …Phrixus Pharmaceuticals Inc.
Entrepreneurs Thomas Collet and Bruce Markham founded Phrixus in 2006 to validate the potential of Carmeseal (P188) to treat heart failure. The Phrixu …Prothelia Inc
Prothelia’s business model with its virtualized operations and low operating expenses focusses exclusively on muscular dystrophy. Benefitting from its …Tivorsan Pharmaceuticals, Inc
Tivorsan Pharmaceuticals is a protein therapeutics company pioneering a unique approach to treating serious neuromuscular disorders, including DMD and …